Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSt James's Place Regulatory News (STJ)

Share Price Information for St James's Place (STJ)

Share Price is delayed by 15 minutes
Get Live Data
1,189.50    -7.00 (-0.59%)
Bid:
1,185.00
Ask:
1,186.50
Spread: 1.50 (0.127%)
Market Cap: £6.05b
STJ Live PriceLast checked at - London Stock Exchange

Intraday St James's Place Share Chart

Director/PDMR Shareholding

16 Mar 2011 15:16

St. James's Place plc ("SJP")

SJP was notified on 15 March 2011 of the following changes in SJP shares held by the executive Directors and Persons Discharging Managerial Responsibilities ("PDMRs") named below.

Award of nil cost options under the SJP Performance Share Plan ("PSP")

On 15 March 2011, the following executive Directors and PDMRs were granted nil cost options under the terms of the PSP over the number of SJP shares set out below:

Name of Director Maximum number of SJP ordinary 15p shares subject to award
David Bellamy 267,322
Andrew Croft 177,912
Ian Gascoigne 177,912
David Lamb 177,912
Mike Wilson 175,264
Name of PDMR Maximum number of SJP ordinary 15p shares subject to award
Adrian Batchelor 40,393
Mike Blunt 38,124
Tony Dunk 38,577
Hugh Gladman 40,393
Mike Gravestock 39,258
Sonia Gravestock 35,173
Bill Tonks 41,527

The awards vest in three years, subject to the achievement of prescribed performance targets over a three-year performance period that commenced on 1 January 2011 and will end on 31 December 2013. Two thirds of an award will be dependent on growth in adjusted earnings per share and one third on total shareholder return. Further details of the performance conditions are set out in the SJP Report & Accounts.

Award of SJP Shares under the SJP Deferred Bonus Scheme ("DBS")

On 15 March 2011, SJP awarded the following ordinary 15p shares under the DBS to the executive Directors and PDMRs named below.

Under the scheme rules, the shares are held by an employee benefit trust (SG Hambros Trust Company (Channel Islands) Limited) on behalf of the executive Directors and PDMRs for a three-year restricted period which will end on 15 March 2014. Until that date, the shares are subject to forfeiture, for example if the executive Director or PDMR leaves SJP.

Name of Director Number of SJP ordinary 15p shares awarded
David Bellamy 77,558
Andrew Croft 58,397
Ian Gascoigne 58,397
David Lamb 58,397
Name of PDMR Number of SJP ordinary 15p shares awarded
Adrian Batchelor 26,977
Mike Blunt 29,198
Tony Dunk 28,286
Hugh Gladman 28,325
Mike Gravestock 30,111
Sonia Gravestock 25,548
Bill Tonks 31,936

The executive Directors and PDMRs shareholdings in SJP after the above transactions are as follows:

Name of Director Beneficial Non-beneficial
David Bellamy 265,877 909,450
Andrew Croft 441,841 134,000
Ian Gascoigne 543,924 30,000
David Lamb 406,519 3,681
Mike Wilson 3,888,361 750,000
Name of PDMR Beneficial Non-beneficial
Adrian Batchelor 225,594 21,497
Mike Blunt 143,347 -
Tony Dunk 182,700 200,959
Hugh Gladman 248,917 -
Mike Gravestock 187,601 -
Sonia Gravestock 186,477 -
Bill Tonks 156,190 14,130

With the exception of the changes notified in this announcement, the executive Directors' and PDMRs' shareholdings in SJP are unchanged.

This notification is made in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).

Deputy Company SecretaryTel: +44 (0)1285 878762

End

Copyright Business Wire 2011

Date   Source Headline
19th Mar 20257:00 amRNSTransaction in Own Shares
18th Mar 20257:00 amRNSTransaction in Own Shares
17th Mar 20257:00 amRNSTransaction in Own Shares
14th Mar 20257:00 amRNSTransaction in Own Shares
13th Mar 20257:00 amRNSTransaction in Own Shares
12th Mar 20257:00 amRNSTransaction in Own Shares
11th Mar 20257:00 amRNSTransaction in Own Shares
10th Mar 20257:00 amRNSTransaction in Own Shares
7th Mar 20257:00 amRNSTransaction in Own Shares
6th Mar 20254:25 pmRNSAnnual Report and Accounts 2024
6th Mar 20251:53 pmRNSDirector/PDMR Shareholding
6th Mar 202512:20 pmRNSDirector/PDMR Shareholding
6th Mar 20257:00 amRNSTransaction in Own Shares
5th Mar 20257:00 amRNSTransaction in Own Shares
4th Mar 20257:00 amRNSTransaction in Own Shares
3rd Mar 202511:10 amRNSTotal Voting Rights
3rd Mar 20257:00 amRNSTransaction in Own Shares
28th Feb 20255:17 pmRNSHolding(s) in Company
28th Feb 20257:00 amRNSShare buy-back programme
27th Feb 20257:00 amRNSFinal Results
7th Feb 202511:22 amRNSHolding(s) in Company
3rd Feb 20253:05 pmRNSBlock listing Interim Review
30th Jan 20257:00 amRNS2024 New Business Inflows & Funds Under Management
23rd Jan 202511:12 amRNSHolding(s) in Company
23rd Dec 20244:57 pmRNSHolding(s) in Company
11th Dec 20249:18 amRNSDirector/PDMR Shareholding
10th Dec 202412:43 pmRNSDirectorate Change
1st Nov 202410:09 amRNSTotal Voting Rights
21st Oct 20243:08 pmRNSHolding(s) in Company
17th Oct 20247:00 amRNSQ3 New Business Inflows and Funds Under Management
1st Oct 202410:41 amRNSTotal Voting Rights
26th Sep 20249:14 amRNSDirector/PDMR Shareholding
16th Sep 202411:19 amRNSCFO Succession Update
16th Sep 20247:00 amRNSTransaction in Own Shares
13th Sep 20247:00 amRNSTransaction in Own Shares
12th Sep 20247:00 amRNSTransaction in Own Shares
11th Sep 20247:00 amRNSTransaction in Own Shares
10th Sep 202411:39 amRNSHolding(s) in Company
10th Sep 20247:00 amRNSTransaction in Own Shares
9th Sep 20247:00 amRNSTransaction in Own Shares
6th Sep 20247:00 amRNSTransaction in Own Shares
5th Sep 20247:00 amRNSTransaction in Own Shares
4th Sep 20247:00 amRNSTransaction in Own Shares
3rd Sep 20247:00 amRNSTransaction in Own Shares
2nd Sep 20242:00 pmRNSTotal Voting Rights
2nd Sep 20247:00 amRNSTransaction in Own Shares
30th Aug 20247:00 amRNSTransaction in Own Shares
29th Aug 20247:00 amRNSTransaction in Own Shares
28th Aug 20247:00 amRNSTransaction in Own Shares
27th Aug 20247:00 amRNSShare buy-back programme

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.